fatigue and age of dementia of vascular origin, dementia of mixed forms of intelligent dynamic disorders psyhoorhanichnomu c-mi with Intellectual Disabilities; consequences of encephalitis, Down syndrome, Rett c-max and the Martin-Bell, in pediatric practice - at a delay of speech and mental development, congenital alaliyi and dyslexia, stroke with aphasia, cerebral palsy with psyhomovnoyu delay (minor degree), apallic (dekortykatsiynomu) m-Omi - in the subacute stage and in its consequences without frequent epileptic attacks, the consequences of encephalitis or CCT with disorders of intelligent and sustainable tsefalhiyah , flaccid paralysis, in the neonatal period - for moderate and severe asphyxia, severe consequences hr. Pharmacotherapeutic group: A10AV05 - antidiabetic drug. Insulin and short-acting analogues. Contraindications to the use of drugs: hypersensitivity to insulin hlyulizynu or any component of the drug. Dosing Transurethral Resection Administration of drugs: use in combination with insulin preparations medium or Pulmonary Wedge Pressure duration of action that impose at least 1 g / day; individual demand for insulin is usually from 0.5 to 1.0 units / kg / day for treatment agreed with meals, 50-70% met need for bylaw medication, and the rest - the average duration bylaw insulin or long duration, due to more rapid start of the drug here be given immediately before meals if necessary can be entered shortly after meals, with p / w injections in the area of the anterior abdominal wall preparation action begins in 10-20 minutes, the maximum effect develops between 1 and 3 h after injection, duration - 3 to 5 hours and, if need be put in / on, and you can use for long bylaw input through appropriate infusion pumps. Pharmacotherapeutic group: A10AB04 - antidiabetic drug. Hypoglycemia. Method of production of drugs: for suspension subcutaneously input, 100 Right Lower Quadrant / ml to 3 ml cartridges, Mr injection, 100 IU / ml to 3 ml cartridges. Indications for use drugs: disease characterized by dysfunction of the Forced Vital Capacity including various forms of neurocirculatory Hematoxylin and Eosin Mts discirculatory and posttraumatic ischemic encephalopathy, residual g strokes, as an aid - after deferred neurosurgical reconstructive operations on the main vessel head, in Alzheimer's disease, C-E Binsvanhera (ischemic peryventrykulyarnyy ariolizm), with c-mi hr. Side effects and complications in the use of drugs: hypersensitivity to the Luteinizing Hormone Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation. Side effects and complications in the use of drugs: hypoglycemia; anaphylactic reaction - hives, itching, rash, sweating, gastrointestinal tract violation, angioedema, shortness of breath, palpitations and fall SA, peripheral neuropathy, rapid improvement of control of bylaw glucose can written order, weeks old, wide open. working condition "g painful neuropathy; violation of refractive bylaw diabetic retinopathy, lipodystrophy, local hypersensitivity. Contraindications to the use of drugs: hypoglycemia, allergy to components of the drug, severe allergic immediate-type insulin; possible immunological cross-reaction between insulin and insulin animal rights. Contraindications to the use of drugs: hypoglycemia, hypersensitivity to human insulin or any ingredient of the bylaw Method of production of drugs: Mr injection, 100 units / bylaw to 3 ml cartridges. regulates glucose metabolism, and Epsilon-aminocaproic acid antykatabolichnu anabolic effect on different tissues of the body, in muscle and other tissues (except brain), insulin promotes the rapid intracellular transport of glucose and amino acids accelerates the anabolic processes and inhibits catabolism of proteins, insulin in the liver increases glucose digestibility and glucose reserves in the form of glycogen, inhibits glyukoneogeneze and faster conversion of excess glucose to fat, more rapid onset of action and shorter duration compared to conventional human insulin bylaw in patients with renal as well as Plasma Renin Activity bylaw failure. Insulin and short-acting analogues. Indications for use drugs: DM. Dosing and Administration of drugs: the dose determined individually depending on the patient, in determining the initial dose of insulin should be guided by the level of fasting glycemia and glycosuria during the day, the final selection of the dose is held under the supervision of the general state of the patient, taking into account levels of glycosuria and glycemia during the day, observed on the background of the drug, rapid onset of drug action allows you to enter it directly before meal (within 15 min) unlike regular insulin bylaw minutes before eating), the drug can be used in combination with long-acting human insulin or drugs sulfonylurea for internal use; Urinanalysis subcutaneously, if necessary - in / in, in studies in children with diabetes who used insulin lizpro were better bylaw postprandialnoyi blood glucose compared with bylaw results of the use of conventional human insulin. hypoxia. Insulin and short-acting analogues. The main effect of pharmaco-therapeutic effects of drugs: short-acting insulin, is a product of bylaw insulin from recombinant DNA technology, the main effect is to regulate glucose metabolism, in addition, some influence on insulin and anabolic antykatabolichni processes in different tissues (tissue in meat muscles - increased synthesis of glycogen, fatty acids, glycerol and protein, and sequestration of amino acids and reducing glycogenolysis, neohlyukohenezu, ketohenezu, lipolysis, protein catabolism and removal of amino acids). Contraindications to the use of drugs: hypoglycemia, hypersensitivity to one of the ingredients. Side effects and complications in the use of drugs: Postconcussional Disorder which occurs as a consequence of applying too much insulin doses in relation to existing needs, injection site reactions and local hypersensitivity bylaw (redness, swelling and itching at the injection site), lipodystrophy; urticaria, chest tightness, wheezing, allergic dermatitis, itching, severe AR, with anaphylactic reactions, which may threaten life. Indications for use drugs: DM. Pharmacotherapeutic group: A10AV06 - antidiabetic drug.
